News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Urigen N.A. Completes Shareholder Meeting


6/29/2007 12:57:16 PM

BURLINGAME, Calif.--(BUSINESS WIRE)-- Urigen N.A., Inc., a specialty pharmaceutical company focused on the development of treatments for urological disorders, has successfully completed its shareholder meeting with Urigen’s shareholders approving the merger with Valentis, Inc.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES